KRYS
Krystal Biotech, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Krystal Biotech (KRYS) Stock: Buy, Sell, or Hold?
$305.23
-0.45 (-0.15%)
▼
5d:
+1.45%
30d:
-7.51%
90d:
-9.08%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 02, 2026
0d
Protect KRYS Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (68%)
Quality Score
39/100
Position
OVERSOLD
30-Day Fair Range
$306.60 – $328.72
Position: OVERSOLD
Forward P/E & Valuation
33.1x
FAIR
vs 31.3x historical avg
Wall Street Target
$388.22
+27.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$281.40 / $317.01
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: KRYS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When KRYS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$363.64
Based on 9.6% avg growth
INTRINSIC VALUE TODAY
$225.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: KRYS is currently trading at $305.23, which is considered oversold relative to its 30-day fair value range of $306.60 to $328.72. The stock's valuation (Forward PE: 33.1) is in line with its historical norms (31.3). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, KRYS is in a strong downtrend. Immediate support is located at $281.40, while resistance sits at $317.00.
Market Sentiment: KRYS scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $388.22 (+27.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KRYS is in a strong downtrend. Immediate support is located at $281.40, while resistance sits at $317.00.
Market Sentiment: KRYS scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $388.22 (+27.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$306.60 -
$328.72
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
68.1%
Trading Range & Key Levels
30-Day Trading Range
$306.60 -
$328.72
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$18.85
(6.2%)
Support Level
$281.40
Resistance Level
$317.01
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding KRYS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.2% below Wall St target ($388.22)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 30.2% revenue growth
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
33.08
Wall Street Target
$388.22
(+27.2%)
Revenue Growth (YoY)
30.2%
Earnings Growth (YoY)
-22.9%
Profit Margin
47.9%
Valuation Premium vs History
+1.8% premium
PE vs Historical
33.1 vs 31.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$310.72
(+2%)
2-Year Target
$316.32
(+4%)
3-Year Target
$322.01
(+6%)
3-Yr Target (if PE normalizes)
(PE: 33→31)
PE COMPRESSION
$304.71
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.1, Growth: 15.2%)
$466.53
(+53%)
Base:
(SPY PE: 19.9, Growth: 15.2%)
$280.11
(-8%)
Bear:
(PE: 16.9, Growth: 15.2%)
$238.09
(-22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 41.96 | Current EPS (TTM): $7.36
Bull Case
$425.90
(+39%)
Analyst growth 25.4%, PE expands to 46.2
Base Case
$387.18
(+27%)
Market implied 25.4%, PE stable at 42.0
Bear Case
$209.99
(-31%)
Severe decline -20.0%, PE contracts to 35.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share KRYS Analysis
Share this live KRYS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KRYS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 2, 2026
Daily AI digest
AI Retail Discussion Summary:
Trader @[handle] expresses bullish sentiment towards $KRYS ahead of its earnings report, citing a strong track record of beating EPS estimates.
Key Retail Themes:
Earnings report
EPS estimates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRYS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 33 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 35 SELL |
|
ARDX
Ardelyx Inc |
STRONG BUY
11 analysts |
$13 | 69 BUY |
Advanced KRYS Option Strategies
Professional options setups generated by AI based on today's KRYS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KRYS Research Pages
